On June 4, 2018, Cryo-Cell International announced it will be acquiring the hybrid public-private cord blood bank CORD:USE for $14 million. The acquisition’s purposes are to strengthen its cord blood banking services by entering the public cord blood sector and to solidify its role as an industry leader. Learn about the combined commercial entity of Cryo-Cell CORD:USE below.
Cryo-Cell CORD:USE | The Acquisition of CORD:USE
In this article:
- Terms of the Cryo-Cell International and CORD:USE Deal
- A Short Background On Cryo-Cell
- About CORD:USE
- U.S. Cord Blood Market Leaders
- GI Partners’s Acquisition of CBR and CCB